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Background
Mechanisms that expand the otherwise narrow neutrali-
zation capacity observed during early HIV-1 infection
are currently undefined, but multiple lines of evidence
suggest that the ability to elicit broad and potent neutra-
lizing antibodies (nAbs) via vaccination could increase
the protective efficacy of immunization.
Methods
Here we characterized the initial nAb response in a sub-
type A HIV-1-infected Rwandan seroconverter and inves-
tigated how consequent immune events influenced the
downstream development of cross-clade breadth. Autolo-
gous envelope (Env) glycoproteins from the transmitted/
founder virus and twenty longitudinal nAb escape variants
were utilized to define the neutralization targets of autolo-
gous plasma and monoclonal antibodies (mAbs), the latter
of which were also examined genetically and structurally
through crystallization. Heterologous Env glycoproteins
from nine cross-clade variants were used to determine
neutralization breadth.
Results
Initially, nAbs targeted a single region of gp120 at the
base of V3 involving the alpha2 helix. A single amino
acid change at one of three positions conferred early
escape from plasma nAbs. Then, two autologous mAbs,
revealed to have flat epitope contact surfaces, typified the
second wave of nAb pressure and neutralized escape
Envs carrying the defined V3/alpha2 helix substitutions
in a manner dependent on immunoglobulin light chain
variable domain modifications. Subsequent mAb resis-
tance arose in later Envs through alteration of two glycan
motifs previously implicated in the development of nAb
breadth. Finally, three-year autologous plasma displayed
moderate neutralization breadth and most potently neu-
tralized heterologous Envs containing the altered glycan
motifs.
Conclusion
Our data demonstrate that the V3-proximal nAb epi-
tope originally recognized in this individual elicited
strain-specific mAbs and that glycan-mediated escape
from these mAbs likely initiated the development of het-
erologous neutralization breadth. These findings suggest
that epitope localization and the resultant routes of viral
immune evasion, which include exposure to a specific
sequence of nAb escape variants, drive humoral immune
responses toward cross-clade viral recognition.
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